Scarica l'app Stockscreener
477.41
3.25%
15.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$462.39
Aprire:
$460.91
Volume 24 ore:
2.10M
Relative Volume:
0.77
Capitalizzazione di mercato:
$180.28B
Reddito:
$43.21B
Utile/perdita netta:
$6.58B
Rapporto P/E:
27.61
EPS:
17.29
Flusso di cassa netto:
$6.17B
1 W Prestazione:
+2.36%
1M Prestazione:
+9.78%
6M Prestazione:
-11.26%
1 anno Prestazione:
-20.31%
Intervallo 1D:
$460.91
$478.19
Intervallo di 1 settimana:
$446.28
$478.19
Portata 52W:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
477.41 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.72 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.27 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
117.32 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.91 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029 | MarketsandMarkets™. - GlobeNewswire Inc.
Heron Therapeutics enters supply agreement with Patheon and Thermo Fisher - Investing.com
Thermo Fisher Scientific (TMO) Oncomine Dx Test Gains FDA Approval for NSCLC Treatment - sg.finance.yahoo.com
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD - Yahoo Finance
Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside - Seeking Alpha
Thermo Fisher's Stock Climbs 0.36% on FDA Diagnostic Approval Surges to 119th in Activity with $790M Volume - AInvest
Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment - Business Wire
Microplate Readers Market Growth and Future Scope 2025-2032 | - openPR.com
Thermo Fisher Scientific – Environmental and Process Monitoring Instruments : Quotes, Address, Contact - AZoMining
Do Tariffs and Buyback Completion Signal a New Strategic Phase for Thermo Fisher (TMO)? - simplywall.st
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - 富途牛牛
Thermo Fisher Scientific: A Deep-Value Buy in a Misunderstood Sector - AInvest
Thermo Fisher Stock Set for Further Re-rating as Market Finds Correct Valuation - AInvest
Thermo Fisher: The Rerating Is Just Getting StartedBuy (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific Stock (TMO) Opinions on $2 Billion Investment Plan - Quiver Quantitative
Fund Update: FLOSSBACH VON STORCH SE added 1,314,182 shares of THERMO FISHER SCIENTIFIC ($TMO) to their portfolio - Quiver Quantitative
U.S. Active Pharmaceutical Ingredients CDMO Market Report 2025-2030 | Competitive Analysis of Thermo Fisher Scientific, Novo Group, Cambrex, Piramal, Corden, Siegfried, Seqens, SK, Noramco, BSP - GlobeNewswire
Thermo Fisher shells out $97m to expand clinical research labs - BioXconomy
Thermo Fisher Tumbles 3.75% on $1.15B Volume Ranks 72nd in Market Activity Amid Mixed Q2 Results and Revised Guidance - AInvest
Thermo Fisher Unveils Next-Gen Electron Microscopes for Enhanced Lab Efficiency - Lab Manager
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets (TMO) - Seeking Alpha
Fund Update: PARNASSUS INVESTMENTS, LLC added 744,827 shares of THERMO FISHER SCIENTIFIC ($TMO) to their portfolio - Quiver Quantitative
Cell Line Development Market Outlook Report 2025-2034: - GlobeNewswire
Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry - Yahoo Finance
Thermo Fisher launches two microscopes - Scientist Live
Drug Screening Market Is Booming So Rapidly 2025-2032 -Thermo - openPR.com
Kovitz Core Equity Strategy Boosts Position in Thermo Fisher Scientific Amidst Tariff Uncertainty - AInvest
Here’s Why Kovitz Core Equity Strategy Increased Its Position in Thermo Fisher Scientific (TMO) - Insider Monkey
Proteomics Market Top PlayersThermo Fisher Scientific, Inc. - openPR.com
Thermo Fisher Scientific Falls 0.03% as $920M Volume Ranks 93rd on Strong Institutional Buying and Upgraded Analyst Targets - AInvest
Thermo Fisher plots 85 layoffs in California as its cost-cutting crusade marches on - Fierce Pharma
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Insider Monkey
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Proteomics Market Growth and Future Scope 2025-2032 | Thermo - openPR.com
Thermo Fisher Scientific introduces Applied Biosystems MagMAX HMW DNA Kit - European Pharmaceutical Manufacturer
Energy giant GE Vernova's market cap is now the largest in Mass. - The Business Journals
Thermo Fisher: New Headwinds Could Delay The Industry's Recovery (NYSE:TMO) - Seeking Alpha
Contract Manufacturing Market Forecast to 2030, with Case Studies of Thermo Fisher Scientific and Flextronics - GlobeNewswire
What makes Thermo Fisher Scientific Inc. stock price move sharplyFree Stock Market Forecast Reports - Jammu Links News
Does Thermo Fisher Scientific Inc. stock perform well during market downturnsBuild a winning investment strategy - Jammu Links News
What are the latest earnings results for Thermo Fisher Scientific Inc.Invest like a pro with expert recommendations - Jammu Links News
What is the dividend policy of Thermo Fisher Scientific Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
What catalysts could drive Thermo Fisher Scientific Inc. stock higher in 2025Breakout stock performance - Jammu Links News
Is Thermo Fisher Scientific Inc. stock overvalued or undervaluedStrong return on investment - jammulinksnews.com
How does Thermo Fisher Scientific Inc. generate profit in a changing economyExplosive trading opportunities - Jammu Links News
How does Thermo Fisher Scientific Inc. compare to its industry peersExplosive market performance - Jammu Links News
Stifel Reaffirms Buy on Thermo Fisher (TMO) Despite Price Target Cut - MSN
Thermo Fisher 2025 Q2 Earnings Strong Performance as Net Income Grows 4% - AInvest
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation - Yahoo Finance
Why Thermo Fisher Scientific Inc. stock attracts strong analyst attentionMomentum Based Equity Trading Plans Reviewed - beatles.ru
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):